DMD Digital Health Connections Group Inc Total Assets
DMD Digital Health Connections Group Inc total assets. Based on the latest financial reports, DMD Digital Health Connections Group Inc (APTOF) holds total assets worth $10.01 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see DMD Digital Health Connections Group Inc market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of DMD Digital Health Connections Group Inc (2013–2025)
Total assets of DMD Digital Health Connections Group Inc from 2013 to 2025. This chart illustrates how DMD Digital Health Connections Group Inc's total assets have evolved over time, based on quarterly financial data. See DMD Digital Health Connections Group Inc share price for real-time trading data and today's change.
DMD Digital Health Connections Group Inc - Asset Composition Analysis
DMD Digital Health Connections Group Inc Total Assets Breakdown (December 2025)
DMD Digital Health Connections Group Inc total assets breakdown as of December 2025. DMD Digital Health Connections Group Inc's total assets of $10.01 Million consist of 64.4% current assets and 35.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how DMD Digital Health Connections Group Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of DMD Digital Health Connections Group Inc to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: DMD Digital Health Connections Group Inc's current assets represent 64.4% of total assets in 2025, an increase from 18.4% in 2013.
- Cash Position: Cash and equivalents constituted 9.0% of total assets in 2025, up from 0.8% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 80.0% in 2013.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
DMD Digital Health Connections Group Inc Competitors by Total Assets
Key competitors of DMD Digital Health Connections Group Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hyloris Developmentsen Sa
BR:HYL
|
Belgium | €37.05 Million |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Oruka Therapeutics, Inc.
NASDAQ:ORKA
|
USA | $1.14 Billion |
|
Gempharmatech Co. Ltd. A
SHG:688046
|
China | CN¥2.80 Billion |
|
Vor Biopharma Inc
NASDAQ:VOR
|
USA | $481.05 Million |
|
Inventiva S.A
PA:IVA
|
France | €249.51 Million |
|
Sunmax Biotechnology Co Ltd
TWO:4728
|
Taiwan | NT$1.90 Billion |
|
Apnimed, Inc. Common Stock
NASDAQ:APMD
|
USA | $342.63 Million |
DMD Digital Health Connections Group Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.69 | 2.14 | 1.71 |
| Quick Ratio | 0.69 | 2.14 | 1.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-2.86 Million | $5.07 Million | $7.20 Million |
DMD Digital Health Connections Group Inc - Advanced Valuation Insights
This section examines the relationship between DMD Digital Health Connections Group Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 93.85 |
| Latest Market Cap to Assets Ratio | 0.43 |
| Asset Growth Rate (YoY) | -1.1% |
| Total Assets | $10.01 Million |
| Market Capitalization | $4.31 Million USD |
Valuation Analysis
Below Book Valuation: The market values DMD Digital Health Connections Group Inc's assets below their book value (0.43x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: DMD Digital Health Connections Group Inc's assets decreased by 1.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for DMD Digital Health Connections Group Inc (2013–2025)
The table below shows the annual total assets of DMD Digital Health Connections Group Inc from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $10.01 Million | -1.14% |
| 2024-12-31 | $10.13 Million | -22.03% |
| 2023-12-31 | $12.99 Million | -74.54% |
| 2022-12-31 | $51.03 Million | -38.17% |
| 2021-12-31 | $82.53 Million | +135.07% |
| 2017-12-31 | $35.11 Million | +6.80% |
| 2016-12-31 | $32.87 Million | +23.76% |
| 2015-12-31 | $26.56 Million | +48.24% |
| 2014-12-31 | $17.92 Million | +12.81% |
| 2013-12-31 | $15.88 Million | -- |
About DMD Digital Health Connections Group Inc
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company's clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed Phase 1/2 clinical trial targeting a select group of kinases operative in myeloi… Read more